Introduction: Survivorship programs to help patients transition from active treatment facilitate symptom management and improve compliance with surveillance. It is not currently established how and where these programs are available for genitourinary (GU) cancer survivors. The purpose of this study is to understand current survivorship resources available among National Cancer Institute designated cancer centers’ websites. Methods: A list of cancer centers was sourced from the National Cancer Institute website. The presence and available services of a survivorship program were assessed using a web-based search by two investigators. Measures of interest included: the presence of GU cancer and general survivorship programs, method of navigation to a survivorship program webpage, the specialty and credentials of survivorship providers, presence of peer support groups, infertility services, and any formal transition tools for cancer treatment to survivorship and surveillance. Results: Among 66 cancer centers, only 12 (19%) had listed GU cancer survivorship programs and 86% had a general cancer survivorship program. For centers with a GU survivorship program, this information was found on a urology department (3, 25%), cancer care (2, 17%), or cancer survivorship webpage (7, 58%). Approximately 7 programs describe provider composition with 3 of 7 having (43%) advanced practice providers, and 4/7 (57%) with physicians. The average time patients are eligible for a survivorship program is about 8 months after treatment (SD 11), or 2 years after diagnosis (SD 2). Among all 66 cancer centers, only 6 (9%) of programs mentioned bladder cancer specific resources, 6 (9%) for renal cancer, 17 (26%) for prostate cancer, and 7 (11%) for testicular cancer. Services and resources among all centers included sexual counseling (19, 30%), nephrology (2, 3%), internal medicine/primary care (16, 25%), reconstructive urology (1, 2%), men’s health/infertility care (12, 19%), sperm-banking (16, 25%), urologic oncology (8, 13%), medical oncology (20, 31%), peer-support (30, 47%), obstetrics and gynecology (17, 26%). Cancer care transitioning tools to survivorship are listed in 16 (25%) cancer centers. Conclusions: Overall, a small portion of cancer centers provided information on GU cancer survivorship care and there is an inter-hospital variation on resources available to GU cancer survivors. While treatment modalities for GU cancers continue to improve, survivorship care for these cancers are lacking, indicating a need to further investigate evidence-based program features and definition. SOURCE OF Funding: None
